Schneider Children's Medical Center
Petah Tikva, 4920235, Israel
Location status: Recruiting
NCT Number: NCT06687434
The goal of this study is to compare qualitative meal-size estimation to accurate carb counting in adolescents with Type One Diabetes using all available AID (Automated Insulin Delivery) systems. We will compare glucose control parameters and patient related outcome measures between the groups. 120 children and adolescents with type 1 Diabetes who begin using AID system will be randomly assigned to one of two groups: simplified qualitative meal size estimation or accurate carb counting. The study will last 6 months, with an additional optional follow up points at 12 and 24 months.
In the first visit all patients will receive nutrition guidance from the dietitian. In the accurate carb counting group, participants will use precise carb counting to manage their meals. In the simplified qualitative meal-size estimation group, participants will use a simplified meal announcement based on three presets for each meal, small, medium, or large, which will be personalized based on the dietitian's assessment. During the study, the dietitian will evaluate the insulin-to-carb ratio and meal estimation at least once in the first two weeks.
Follow-up visits will be scheduled at 4-6 weeks, 3, and 6 months after the study's initiation. At each visit participants will upload their data from their AID systems. Evaluation of their diabetes control will be made and an assessment regarding the carbohydrates calculation method. Digital questionnaires assessing diabetes distress, disordered eating behaviors, dietary regimen, and eating patterns will be provided at the beginning of the study and after 6 months, with an additional optional follow-up points that will be held at 12 and 24 months after the study's initiation.
Interested in participating?
Request Info6 year–18 year
All sexes
Interventional
Not applicable
Petah Tikva, 4920235, Israel
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will use precise carb counting to manage their meals
participants will use a simplified meal announcement based on three presets for each meal, small, medium, or large, which will be personalized based on the dietitian's assessment.
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Time frame: Screening, after 4-6 weeks, after 3 months and after 6 months
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: at screening, after 4-6 weeks, after 3 months and after 6 months.
Time frame: At screening and after 6 months
Time frame: At screening and after 6 months
Time frame: At screening and after 6 months
Contact information is provided by the study sponsor or research team.
Michal Gilon Keren, Phd
CONTACT
Tal Oron, DR.
CONTACT
Rabin Medical Center
Other
Carb Counting vs. Simplified Qualitative Meal-Size Estimation- A Randomized Control Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06783309
Autoimmune Diseases, Diabetes Mellitus
Tucson, Arizona, United States
View Trial DetailsNCT07548996
Autoimmune Diseases, Diabetes Mellitus
Nanjing, Jiangsu, China
View Trial DetailsNCT07593625
Autoimmune Diseases, Diabetes (DM)
Christchurch, New Zealand
View Trial DetailsNCT07149142
Autoimmune Diseases, Cardiovascular Diseases
Prague, Prague 5, Czechia
View Trial Details